The authors have carried out a study of the efficacy of Genocard using for conservative treatment and postoperative correction of disuric symptoms in patients suffering from benign prostatic hyperplasia and concomitant chronic prostatits. Treatment efficacy has been corroborated by clinical, laboratory and sonographic trials.
